US Expansion Arrayjet is expanding into the US with a dedicated printing suite in Bend, Oregon, in collaboration with GraceBio Labs, signaling a direct channel for instrument sales, printing services, and on-site deployment to US pharma, diagnostics, and life-science customers.

High Throughput Edge The platform delivers high-speed, high-density microarray printing with real-time quality assurance and tight environmental controls, enabling faster screening and reproducible results. Sales opportunities include targeting drug discovery, antibody characterization, and gene expression profiling teams that require scalable, cost-efficient printing and long-term service agreements.

Key Collaborations Strategic partnerships with Immunome, Chemspace, and GraceBio showcase a collaborative model and access to broad libraries and assay capabilities. BD can position Arrayjet as an integrated screening and assay development partner for CROs and biotechs seeking streamlined workflows and data-rich outputs.

Portfolio Growth Mercury launch and NA presence expand the instrument portfolio and regional sales capacity, enabling ultra-low-volume dispensing and broader customer reach. Opportunities include targeting labs needing low-volume handling and cross-selling ArrayPlex-based screening services with enhanced data normalization.

Quality Advantage ISO 13485:2016 compliant facility strengthens credibility with medical devices and regulated diagnostics customers; emphasize quality, traceability, and regulatory readiness as differentiators. Opportunities include targeting pharmaceutical manufacturers, contract labs, and diagnostic developers requiring validated processes and compliant data.